透景生命：取得医疗器械变更注册文件

Core Viewpoint - The company has received a change registration document from the National Medical Products Administration for its HPV nucleic acid detection kit, which is expected to enhance market expansion capabilities and positively impact future operations [1] Group 1 - The company has completed the change of registration for the "HPV Nucleic Acid Detection and Typing Kit (Fluorescent PCR Method)" [1] - The kit is designed for qualitative detection of 14 types of HPV nucleic acids in cervical exfoliated cells, specifically typing HPV16 and HPV18 [1] - This change aims to better meet the diverse testing needs of end customers [1]